Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$535,014,015
-$81,271,391 QoQ
Shares Held
22,218,190
+1.2% QoQ
Ownership
0.390%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#26
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital World Investors holds $50,250,725,849 across 10 Drug Manufacturers - General names. PFE ranks #7 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,902,642 | $19,074,107,484 | |
| 2 | AMGN |
Amgen Inc
|
29,075,329 | $10,528,758,137 | |
| 3 | AZN |
Astrazeneca PLC
|
30,075,134 | $5,702,846,909 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
40,988,975 | $5,178,547,101 | |
| 5 | ABBV |
AbbVie Inc.
|
19,178,966 | $4,826,195,004 | |
| 6 | JNJ |
Johnson & Johnson
|
15,215,015 | $3,864,157,359 | |
| 7 | PFE |
Pfizer Inc
This page
|
22,218,190 | $535,014,015 | |
| 8 | NVO |
Novo Nordisk A S
|
5,205,926 | $249,572,092 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $535,014,015 | 22,218,190 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $616,285,406 | 21,947,486 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $533,703,861 | 21,433,890 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $360,457,814 | 14,146,696 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $335,971,320 | 13,860,203 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $689,969,607 | 27,228,477 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,157,116,774 | 43,615,408 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,553,736,652 | 53,688,205 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,466,231,738 | 88,142,664 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,126,356,097 | 112,661,481 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,992,021,090 | 173,394,272 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $6,043,317,993 | 182,192,282 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,299,789,724 | 199,012,806 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $9,445,704,614 | 231,512,368 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $13,122,400,236 | 256,096,804 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $10,889,699,149 | 248,850,529 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,114,145,345 | 250,126,747 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $11,382,971,977 | 219,875,835 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $13,986,489,464 | 236,858,416 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $10,380,930,502 | 241,360,858 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,405,817,491 | 240,189,415 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $8,336,030,054 | 230,086,394 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $9,815,298,818 | 266,647,618 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $9,512,127,717 | 259,186,297 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,993,147,506 | 244,438,509 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,337,726,871 | 224,808,113 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||